Himalaya Nutravedics India share price
BSE: 544943Pharmaceuticals & Biotechnology
Last close ₹137.20₹0.00 (0.00%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹137.20.
Range of traded prices from listing on 29 Sep 2026 to 23 Oct 2026
₹111.00Low, 1 Oct 2026₹167.20High, 15 Oct 2026
- Under BSE's short-term additional surveillance, stage I, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹121 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, BSEVolume. Shares traded on the last trading day.
- 12,000
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Himalaya Nutravedics India in market cap.
Himalaya Nutravedics India is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Par Drugs and ChemicalsPAR | 127 | 8.8 | 1.1 | 4.3 | +4.3% | +2.4% | 13.7% | 14.5% | 0.00% |
 Lactose (India)LACTOSE | 125 | 18.1 | 1.9 | 9.6 | +34.9% | +57.8% | 11.2% | 10.6% | 0.00% |
 Speciality MedicinesSPML | 125 | 9.6 | 1.7 | – | – | – | 18.3% | – | 0.00% |
 Godavari DrugsGODAVARI | 122 | 29.3 | 1.6 | 18.5 | +4.8% | +9.7% | 7.0% | 4.9% | 0.00% |
 Parnax LabPARNAXLAB | 119 | 13.3 | 1.2 | 7.9 | +31.9% | −17.3% | 10.0% | 9.3% | 0.00% |
 BALAXI PHARMACEUTICALSBALAXI | 115 | 47.6 | 0.5 | 17.3 | −5.9% | −87.2% | 1.0% | 2.1% | 0.00% |
 Krebs Biochemicals and IndustriesKREBSBIO | 112 | – | – | – | −29.7% | – | – | −14.4% | 0.00% |
 Makers LaboratoriesMAKERSL | 110 | 32.3 | 1.5 | 6.1 | +17.6% | −61.6% | 4.8% | 11.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
16 Oct · Legal
Exchange has sought clarification from Himalaya Nutravedics India Ltd on October 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....4 Oct · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Commercial Suit Filed Against The Company
Sep 2026
29 Sep · Listing of Equity Shares of Himalaya Nutravedics India Ltd
Trading Members of the Exchange are hereby informed that effective from September 29, 2026, the Equity Shares of Himalaya Nutravedics India Ltd (Scrip Code: 544943) are listed and admitted ....
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 138.05 | 138.05 | 133.00 | 137.20 | 137.32 | 12,000 |
| 22 Oct 2026 | 118.00 | 144.95 | 118.00 | 137.20 | 134.66 | 20,400 |
| 21 Oct 2026 | 134.00 | 134.00 | 122.00 | 123.55 | 125.86 | 32,400 |
| 19 Oct 2026 | 147.00 | 147.00 | 132.05 | 134.35 | 137.92 | 54,000 |
| 16 Oct 2026 | 157.00 | 162.95 | 142.05 | 149.60 | 151.22 | 98,400 |
| 15 Oct 2026 | 148.50 | 167.20 | 148.50 | 156.30 | 159.45 | 86,400 |
| 14 Oct 2026 | 125.00 | 143.90 | 123.75 | 143.85 | 137.57 | 3,38,400 |
| 13 Oct 2026 | 119.90 | 119.95 | 119.90 | 119.95 | 119.91 | 64,800 |
| 12 Oct 2026 | 112.05 | 122.45 | 111.05 | 114.25 | 119.42 | 38,400 |
| 9 Oct 2026 | 119.00 | 119.00 | 116.65 | 116.65 | 117.03 | 22,800 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- HIMALAYA NUTRAVEDICS INDIA LIMITED
- BSE code
- 544943
- ISIN
- INE1OTR01013
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Sep 2026
- Face value
- ₹10
- CIN
- U24110TG2022PLC163732
- Corporate identity number, the registrar of companies' code for it
In BSE SME IPO